Online access to latest application solutions
Shimadzu has launched two new tools giving online access to latest application solutions: a Special Edition of the customer magazine Shimadzu-News specifically for the needs of the pharmaceutical industry, and a News App for iPhone®and iPod® touch featuring the Shimadzu-News.
Shimadzu has launched two new tools giving online access to latest application solutions: a Special Edition of the customer magazine Shimadzu-News specifically for the needs of the pharmaceutical industry, and a News App for iPhone® and iPod® touch featuring the Shimadzu-News.
The 40 page Shimadzu News Pharma Special introduces solutions and applications for a multitude of topics such as drug research, development and testing as well as method development, manufacturing and quality control. The in-depth articles cover many disciplines of analytical instrumentation, e.g. chromatography, TOC and spectroscopy.
Shimadzu Pharma News is available for download at www.shimadzu.eu or via App for iPhone® and Android (mobile download Shimadzu News WebApp / Shimadzu News App). A printed version can also be ordered directly from Shimadzu Europa.
News App for iPhone® and iPod® touch
Users of Apple mobile devices can now contact Shimadzu directly, independent of PC or notebook. Users benefit from an iOS optimized version of the customer magazine Shimadzu News for iPhone and iPod touch that even works on the iPad®. Additional functions such as overviews on markets or product related articles, an internal search function and the ‘MyShimadzu’ section complete the offer.
The News App can be downloaded from the App Store. The News App will self-install.
iPhone®, iPad® and iPod® are registered trademarks of Apple Inc. in the United States and/or other countries.
Transformations in Drug Development for Cell and Gene Therapies
March 28th 2025As a recognized leader in immunophenotyping for clinical trials, Kevin Lang from PPD discusses how spectral flow cytometry is transforming drug development, particularly in cell and gene therapies like CAR-T. He also dives into his award-winning research, including his 2024 WRIB Poster Award-winning work, and his insights from presenting at AAPS PharmSci360.
Advancing Clinical Trials with Spectral Flow Cytometry: A Conversation with Kevin Lang
March 28th 2025As a recognized leader in immunophenotyping for clinical trials, Kevin Lang from PPD discusses how spectral flow cytometry is transforming drug development, particularly in cell and gene therapies like CAR-T. He also dives into his award-winning research, including his 2024 WRIB Poster Award-winning work, and his insights from presenting at AAPS PharmSci360.
Pharmaceutical Tariffs Are Imminent: How Industry is Bracing for Impact
April 16th 2025On April 14, 2025, the Trump Administration launched a national security-driven investigation into pharmaceuticals, a move that will likely result in tariffs being placed on pharmaceutical drugs, ingredients, and other components that are imported from outside of the United States.
